Physician profile
William A Facibene
NPI 1699862268
$721.72
in general payments reported to CMS, 2019-2025
11 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.84 · 2020: $22.08 · 2022: $129 · 2023: $201 · 2024: $250 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $228.79 | 2019-2024 | Xiaflex |
| Djo, LLC | $128.21 | 2023-2025 | Cmf |
| Depuy Synthes Sales INC. | $68.78 | 2022-2024 | Monovisc, Orthovisc |
| Endo USA, INC. | $68.32 | 2024-2025 | Xiaflex |
| Stryker Corporation | $55.23 | 2024 | Pangea |
| Bioventus LLC | $45.88 | 2024 | Gelsyn-3, Supartz Fx Sodium Hyaluronate |
| Osteomed LLC | $35.37 | 2022 | |
| Becton, Dickinson and Company | $29.65 | 2023 | |
| Integra Lifesciences Corporation | $28.36 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acumed LLC | $19.09 | 2023 | Osteomed |
| Ferring Pharmaceuticals INC. | $14.04 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Facibene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.